ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 56 filers reported holding ADC THERAPEUTICS SA in Q3 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,288,000 | -27.3% | 1,517,212 | 0.0% | 4.35% | +37.3% |
| Q4 2021 | $30,648,000 | -25.6% | 1,517,212 | 0.0% | 3.17% | -37.2% |
| Q3 2021 | $41,207,000 | +11.5% | 1,517,212 | 0.0% | 5.05% | +37.6% |
| Q2 2021 | $36,944,000 | -0.2% | 1,517,212 | 0.0% | 3.67% | +34.9% |
| Q1 2021 | $37,035,000 | -23.7% | 1,517,212 | 0.0% | 2.72% | +2.8% |
| Q4 2020 | $48,566,000 | -3.0% | 1,517,212 | 0.0% | 2.65% | -28.3% |
| Q3 2020 | $50,053,000 | -16.3% | 1,517,212 | +18.8% | 3.69% | -33.7% |
| Q2 2020 | $59,786,000 | – | 1,277,212 | – | 5.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $9,430,000 | 5.29% |
| GCM Grosvenor Holdings, LLC | 1,298,012 | $10,319,000 | 2.33% |
| Redmile Group, LLC | 7,512,029 | $59,721,000 | 2.28% |
| MPM BioImpact LLC | 334,384 | $2,658,000 | 0.74% |
| Indie Asset Partners, LLC | 93,989 | $747,000 | 0.66% |
| Eventide Asset Management | 1,879,959 | $14,946,000 | 0.32% |
| Walleye Capital LLC | 888,700 | $7,065,000 | 0.20% |
| Endurant Capital Management LP | 58,967 | $469,000 | 0.16% |
| HHLR ADVISORS, LTD. | 500,000 | $3,975,000 | 0.08% |
| Matrix Capital Management Company, LP | 400,000 | $3,180,000 | 0.07% |